General Motors Company

GM is profitable on an adjusted basis. Q1 2026 adjusted EPS of $3.70 beat the $2.62 consensus by 41%, helped by a ~$500M benefit from a Supreme Court ruling that terminated certain IEEPA tariff levies. North America carried the result, with adjusted EBIT of $3.7B at a 10.1% margin (roughly 8.6% underlying, excluding the tariff benefit).

The GAAP view is softer: gross margin compressed from 12.2% to 11.5%, GAAP operating income fell ~14.9% YoY on $1.1B of EV-related restructuring charges, and the trailing net margin is around 1.7%. The company raised full-year 2026 guidance after Q1. Q4'25 and Q3'25 figures are approximate from filings and analyst consensus; Q4'25 included large one-time charges.

On the surface GM looks cheap: a forward P/E around 6x on FY2026 estimates and a PEG near 0.5x, below Peter Lynch's 1.0 threshold. But long-term earnings growth is estimated at only ~4–5% a year, which raises the classic value-trap question of whether current earnings are near a cyclical peak. In Lynch's terms the stock reads as value-priced rather than a true growth story.

Catalysts: a GM/Lockheed defense MOU (new revenue diversification), OnStar digital services growing 20%+ (on track for ~$3.1B in FY2026), shrinking EV losses, and a $6B buyback authorized in January 2026. Headwinds: a guided $3–4B annual tariff cost, a China JV under sustained pressure from BYD, GAAP earnings expected to decline ~4.4% a year, and a strategic pivot away from next-gen electric trucks. ROE is forecast near 17.8%, Q1 free cash flow rose sharply YoY, and the dividend yield is modest at ~0.87%.

GM surged from a 52-week low of $47.63 to an all-time closing high of $85.99 (Jan 27, 2026), a run of more than 80% in about a year. That Stage 2 uptrend is now showing exhaustion: the stock has not reclaimed its January highs, sits ~9% below the peak, and trades below both the 50-day ($80.26) and 200-day ($82.01) moving averages, with volume elevated on down days.

The structure is transitioning from Stage 2 into early Stage 3 (distribution/topping), not yet a confirmed Stage 4 decline, but clearly losing upside momentum. This is a distribution posture rather than the accumulation/basing setup that typically precedes a new advance.

The technical posture is weak. The June 17 decline of ~3.5% to $79.58 keeps the stock below both its 50-day and 200-day moving averages, the MACD is negative at −0.94, and a daily composite reads 8 sell signals versus 4 buys. The 14-day RSI of 41 is approaching, but not yet at, oversold (30), which suggests room for further downside before a bounce.

Price sits in the middle of its recent 30-day range ($70.43–$85.41) without a clear bottom, with a Fibonacci pivot near $77.47 as possible support. The decline came on elevated volume, and recent sessions have shown higher volume on down days, consistent with institutional distribution.

Implied volatility is near its 52-week lows (IV ~32.8%, IV Rank 5, IV percentile 2), an unusually quiet reading that historically precedes a volatility expansion. The pullback to $79.58 has pushed price below the lower 25-day Bollinger band, a mean-reversion signal in isolation but one that can mark continuation within a broader downtrend.

There is no cup-and-handle, bull flag, or classic squeeze forming. With the average true range expanding, the price action looks more like distribution than the constructive base-building that usually marks a low-risk setup.

The 30-day newsflow is two-sided. Strong fundamental items (the Lockheed defense MOU, the Q1 beat and guidance raise) sit against a clear negative: heavy insider selling, including the president reportedly selling roughly 73% of his direct holding. Insiders have been net sellers of about $86M over the past twelve months.

GM has massively outperformed over the trailing year (+72%), but 2026 to date has stalled (−2.9%) as the stock corrects from its January all-time high, recently lagging Ford. Institutions are the dominant holders, though elevated protective-put activity suggests some are hedging, and the $6B buyback provides structural demand. Average daily volume is ~7.55M, with recent weight on down days.

Published analyst coverage remains broadly constructive even as the technicals deteriorate (a GuruFocus GF Score of 77/100), creating a notable gap between sell-side optimism and a weakening chart and insider behaviour.

GM's macro backdrop is a web of headwinds with one emerging tailwind. Tariffs are the largest quantified risk ($3–4B), China continues to deteriorate, and higher-for-longer rates keep auto affordability tight. The offset is the Lockheed defense MOU, which lets GM turn idle commercial capacity toward higher-margin government work, potentially a durable structural change. The business has historically been highly sensitive to consumer confidence, interest rates, and trade policy, all of which are unsettled now.

General Motors is a study in cheap-but-cyclical. The stock screens as inexpensive, at roughly 6x forward earnings and a PEG near 0.5x, and a new GM/Lockheed defense MOU offers genuine revenue diversification beyond autos. The offsets are just as clear: the chart has rolled over into a distribution/topping posture below both its 50- and 200-day moving averages, GAAP margins and earnings are under pressure, a ~$3–4B annual tariff bill and a BYD-pressured China JV cloud the outlook, and insiders have been heavy net sellers (~$86M over twelve months). The valuation is genuinely low; the question the chart and the insiders raise is whether current earnings are near a cyclical peak.

Supporting factors

Risk factors

What's working: a strikingly low valuation (~6x forward earnings, PEG ~0.5x), a 41% Q1 adjusted-EPS beat with raised guidance, a new defense-manufacturing agreement with Lockheed that uses idle plant capacity, OnStar digital services growing 20%+, shrinking EV losses, and a $6B buyback supporting per-share earnings.

What to weigh: the technical picture has turned (price below the 50- and 200-day moving averages, a negative MACD, distribution volume), insiders have sold roughly $86M net over the past year, GAAP margins and earnings are compressing, and a ~$3–4B annual tariff bill plus a deteriorating China JV cloud the outlook. The cheapness may reflect cyclical, possibly peak, earnings rather than a lasting bargain.